Your browser doesn't support javascript.
loading
Hepatobiliary phenotypes of adults with alpha-1 antitrypsin deficiency.
Fromme, Malin; Schneider, Carolin V; Pereira, Vitor; Hamesch, Karim; Pons, Monica; Reichert, Matthias C; Benini, Federica; Ellis, Paul; H Thorhauge, Katrine; Mandorfer, Mattias; Burbaum, Barbara; Woditsch, Vivien; Chorostowska-Wynimko, Joanna; Verbeek, Jef; Nevens, Frederik; Genesca, Joan; Miravitlles, Marc; Nuñez, Alexa; Schaefer, Benedikt; Zoller, Heinz; Janciauskiene, Sabina; Abreu, Nélia; Jasmins, Luís; Gaspar, Rui; Liberal, Rodrigo; Macedo, Guilherme; Mahadeva, Ravi; Gomes, Catarina; Schneider, Kai Markus; Trauner, Michael; Krag, Aleksander; Gooptu, Bibek; Thorburn, Douglas; Marshall, Aileen; Hurst, John R; Lomas, David A; Lammert, Frank; Gaisa, Nadine T; Clark, Virginia; Griffiths, William; Trautwein, Christian; Turner, Alice M; McElvaney, Noel G; Strnad, Pavel.
Afiliação
  • Fromme M; Medical Clinic III, Gastroenterology, Metabolic Diseases and Intensive Care, University Hospital RWTH Aachen, Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN RARE LIVER), Aachen, Germany.
  • Schneider CV; Medical Clinic III, Gastroenterology, Metabolic Diseases and Intensive Care, University Hospital RWTH Aachen, Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN RARE LIVER), Aachen, Germany.
  • Pereira V; Department of Gastroenterology, Centro Hospitalar do Funchal, Madeira, Portugal.
  • Hamesch K; Medical Clinic III, Gastroenterology, Metabolic Diseases and Intensive Care, University Hospital RWTH Aachen, Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN RARE LIVER), Aachen, Germany.
  • Pons M; Liver Unit, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute (VHIR), Universitat Autonoma de Barcelona, Barcelona, Catalunya, Spain.
  • Reichert MC; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Comunidad de Madrid, Spain.
  • Benini F; Department of Medicine II, Saarland University Medical Center, Saarland University, Homburg, Germany.
  • Ellis P; Gastroenterology Unit, Department of Medicine, Spedali Civili and University, Brescia, Italy.
  • H Thorhauge K; Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
  • Mandorfer M; Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark.
  • Burbaum B; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN RARE LIVER), Vienna, Austria.
  • Woditsch V; Medical Clinic III, Gastroenterology, Metabolic Diseases and Intensive Care, University Hospital RWTH Aachen, Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN RARE LIVER), Aachen, Germany.
  • Chorostowska-Wynimko J; Medical Clinic III, Gastroenterology, Metabolic Diseases and Intensive Care, University Hospital RWTH Aachen, Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN RARE LIVER), Aachen, Germany.
  • Verbeek J; Department of Genetics and Clinical Immunology, National Tuberculosis and Lung Diseases Institute, Warszawa, Poland.
  • Nevens F; Department of Gastroenterology & Hepatology, KU Leuven University Hospitals Leuven, Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN RARE LIVER), Leuven, Flanders, Belgium.
  • Genesca J; Department of Gastroenterology & Hepatology, KU Leuven University Hospitals Leuven, Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN RARE LIVER), Leuven, Flanders, Belgium.
  • Miravitlles M; Liver Unit, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute (VHIR), Universitat Autonoma de Barcelona, Barcelona, Catalunya, Spain.
  • Nuñez A; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Comunidad de Madrid, Spain.
  • Schaefer B; Pneumology Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Campus, CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Spain.
  • Zoller H; Pneumology Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Campus, CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Spain.
  • Janciauskiene S; Department of Internal Medicine I, Medical University of Innsbruck, Innsbruck, Tirol, Austria.
  • Abreu N; Department of Internal Medicine I, Medical University of Innsbruck, Innsbruck, Tirol, Austria.
  • Jasmins L; Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany.
  • Gaspar R; Department of Gastroenterology, Centro Hospitalar do Funchal, Madeira, Portugal.
  • Liberal R; Department of Gastroenterology, Centro Hospitalar do Funchal, Madeira, Portugal.
  • Macedo G; Gastroenterology Department, Centro Hospitalar de São João, Faculty of Medicine of Porto University, Porto, Portugal.
  • Mahadeva R; Gastroenterology Department, Centro Hospitalar de São João, Faculty of Medicine of Porto University, Porto, Portugal.
  • Gomes C; Gastroenterology Department, Centro Hospitalar de São João, Faculty of Medicine of Porto University, Porto, Portugal.
  • Schneider KM; Department of Respiratory Medicine, Cambridge University Hospitals, Cambridge, UK.
  • Trauner M; Gastroenterology Department, Centro Hospitalar de Vila Nova de Gaia Espinho EPE, Vila Nova de Gaia, Porto, Portugal.
  • Krag A; Medical Clinic III, Gastroenterology, Metabolic Diseases and Intensive Care, University Hospital RWTH Aachen, Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN RARE LIVER), Aachen, Germany.
  • Gooptu B; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN RARE LIVER), Vienna, Austria.
  • Thorburn D; Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark.
  • Marshall A; NIHR Leicester BRC-Respiratory and Leicester Institute of Structural & Chemical Biology, University of Leicester, Leicester, Leicestershire, UK.
  • Hurst JR; London Alpha-1 Antitrypsin Deficiency Service, Royal Free Hospital, London, UK.
  • Lomas DA; London Alpha-1 Antitrypsin Deficiency Service, Royal Free Hospital, London, UK.
  • Lammert F; Sheila Sherlock Liver Unit and UCL Institute for Liver and Digestive Health, Royal Free Hospital, London, UK.
  • Gaisa NT; London Alpha-1 Antitrypsin Deficiency Service, Royal Free Hospital, London, UK.
  • Clark V; Sheila Sherlock Liver Unit and UCL Institute for Liver and Digestive Health, Royal Free Hospital, London, UK.
  • Griffiths W; London Alpha-1 Antitrypsin Deficiency Service, Royal Free Hospital, London, UK.
  • Trautwein C; UCL Respiratory, Division of Medicine, University College London, London, UK.
  • Turner AM; London Alpha-1 Antitrypsin Deficiency Service, Royal Free Hospital, London, UK.
  • McElvaney NG; UCL Respiratory, Division of Medicine, University College London, London, UK.
  • Strnad P; Department of Medicine II, Saarland University Medical Center, Saarland University, Homburg, Germany.
Gut ; 71(2): 415-423, 2022 02.
Article em En | MEDLINE | ID: mdl-33632708
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Colelitíase / Deficiência de alfa 1-Antitripsina / Cirrose Hepática / Neoplasias Hepáticas Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Gut Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Colelitíase / Deficiência de alfa 1-Antitripsina / Cirrose Hepática / Neoplasias Hepáticas Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Gut Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha